Is Oragenics Inc (OGEN) overvalued? · rev $37.7K
Oragenics Inc (OGEN) is a biotechnology company listed on US.
This page asks whether Oragenics Inc (OGEN) looks expensive on cached numbers — not a short thesis.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
OGEN currently screens at market cap $2.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next OGEN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the OGEN stock page for the full model, not this heading.
Not investment advice.